Novel Uses of Neuraminidase Inhibitors in Infectious Diseases
OwnerJack J. Broadhurstinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of decreasing the infectivity, morbidity and rate of mortality, in treating diseases associated with a variety of pathogenic organisms, specifically diseases involving one or more pathogens that require neuraminidase as a virulence factor. In addition, the present invention uses biology based therapy to treat neuraminidase dependent infections or diseases dependent on sialic acid metabolism.
Claims6
A method for inhibiting neuraminidase dependent bacterial infections that are not viral generated dependent infections, wherein the neuraminidase dependent bacterial infections that are not viral generated infections are from a disease-causing microorganism dependent on sialic acid metabolism, whereby the microorganism comprises a bacterial species selected from the group consisting of Clostridium, Enterococcus, Enterobacteriaceae, Escherichia coli, Acinetobacter, Pasteurella, Campylobacterium, Klebsiella, Pseudomonas, Neisseria, Salmonella, Shigella, Staphylococcus, Streptococcus and Vibrio, comprising administering to an animal in need thereof a therapeutically effective amount of a composition comprising one or more compounds, wherein one of the compounds comprises oseltamivir phosphate.
A method for treating neuraminidase dependent bacterial infections from a disease-causing microorganism dependent on sialic acid metabolism, whereby the microorganism comprises a bacterial species selected from the group consisting of Clostridium, Enterococcus, Enterobacteriaceae, Escherichia coli, Acinetobacter, Pasteurella, Campylobacterium, Klebsiella, Pseudomonas, Neisseria, Salmonella, Shigella, Staphylococcus, Streptococcus and Vibrio, comprising administering to an animal in need thereof a therapeutically effective amount of a composition comprising one or more compounds, wherein one of the compounds comprises oseltamivir phosphate.
Dependencies are inferred from the claim text.